Actively Recruiting

Age: 18Years +
All Genders
NCT04130789

Personalized Swiss Sepsis Study

Led by University Hospital, Basel, Switzerland · Updated on 2025-03-05

17500

Participants Needed

16

Research Sites

315 weeks

Total Duration

On this page

Sponsors

U

University Hospital, Basel, Switzerland

Lead Sponsor

S

Swiss Personalized Health Network (SPHN)

Collaborating Sponsor

AI-Summary

What this Trial Is About

This multi-center study is to focus on patients with sepsis in Intensive Care Units (ICUs) in order to better understand the complex host-pathogen interaction and clinical heterogeneity associated with sepsis. Understanding this heterogeneity may allow the development of novel diagnostic approaches. Data from patients will be analyzed using state-of-the art analytical algorithms for biomarker discovery including machine learning and multidimensional mathematical modelling to explore the large datasets generated. In order to discover digital biomarkers for the study endpoints a case-control study design will be used to compare data patterns from patients with sepsis (cases) and those without sepsis (controls).

CONDITIONS

Official Title

Personalized Swiss Sepsis Study

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Patients admitted to an ICU at a Swiss University Hospital
  • Patients expected to stay at least 24 hours in the ICU
  • Cases: Patients with sepsis 3.0 criteria at ICU admission or who develop sepsis during ICU stay
  • Controls: Patients not meeting sepsis criteria during ICU stay
Not Eligible

You will not qualify if you...

  • Declined general consent or any refusal to use data for research
  • Patients with a planned elective stay in the ICU

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 16 locations

1

Clinical Microbiology, University Hospital Basel

Basel, Switzerland, 4031

Actively Recruiting

2

Infectious Diseases and Hospital Epidemiology, University Hospital Basel

Basel, Switzerland, 4031

Actively Recruiting

3

Medical Intensive Care Unit; University Hospital Basel

Basel, Switzerland, 4031

Actively Recruiting

4

Surgical Intensive Care Unit, University Hospital Basel

Basel, Switzerland, 4031

Actively Recruiting

5

Institute for Infectious Diseases, University of Bern

Bern, Switzerland, 3001

Actively Recruiting

6

Division Infectious Diseases, University Hospital Bern

Bern, Switzerland, 3010

Actively Recruiting

7

Intensive Care Medicine, University Hospital Bern

Bern, Switzerland, 3010

Actively Recruiting

8

Division Bacteriology Laboratory, University Hospital Geneva

Geneva, Switzerland, 1205

Actively Recruiting

9

Division Infectious Diseases, University Hospital Geneva

Geneva, Switzerland, 1205

Actively Recruiting

10

Intensive Care Medicine, University Hospital Geneva

Geneva, Switzerland, 1205

Actively Recruiting

11

Division Intensive Care Medicine, University Hospital Lausanne

Lausanne, Switzerland, 1011

Actively Recruiting

12

Institute of Microbiology, University Hospital Lausanne

Lausanne, Switzerland, 1011

Actively Recruiting

13

Service Infectious Diseases, University Hospital Lausanne

Lausanne, Switzerland, 1011

Actively Recruiting

14

Institute for Medical Microbiology, University Hospital Zurich

Zurich, Switzerland, 8006

Not Yet Recruiting

15

Division Infectious Diseases, University Hospital Zurich

Zurich, Switzerland, 8091

Not Yet Recruiting

16

Institute for Intensive Medicine, University Hospital Zurich

Zurich, Switzerland, 8091

Not Yet Recruiting

Loading map...

Research Team

A

Adrian Egli, PD Dr.

CONTACT

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here